Joseph M. Busky - May 27, 2022 Form 4 Insider Report for QuidelOrtho Corp (QDEL)

Role
Chief Financial Officer, Director
Signature
/s/ Phillip S. Askim, attorney-in-fact for Joseph M. Busky
Stock symbol
QDEL
Transactions as of
May 27, 2022
Transactions value $
$0
Form type
4
Date filed
6/1/2022, 05:31 PM
Next filing
Jun 3, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction QDEL Stock Options Award $0 +21K $0.00 21K May 27, 2022 Common Stock 21K $119.06 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Pursuant to the Business Combination Agreement, dated as of December 22, 2021 (the "Business Combination Agreement") by and among Quidel Corporation, Ortho Clinical Diagnostics Holdings plc ("Ortho"), QuidelOrtho Corporation ("QuidelOrtho"), Orca Holdco, Inc., Laguna Merger Sub, Inc. and Orca Holdco 2, Inc., each Ortho stock option was converted into a Stock Option to purchase shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions), except as adjusted by the Business Combination Agreement.
F2 7,003 shares will vest on July 7, 2022 and 7,006 shares will vest on July 7, 2023.